Activation of the herpes simplex virus type 2 (HSV-2) large subunit of the ribonucleotide reductase (ICP10) gene by papillomavirus DNA encoding the E2 or E7 proteins was studied directly by immunofluorescence or by chloramphenicol acetyltransferase (CAT) analysis with hybrid ICP10 or IE175 and 38K promoter constructions. Cotransfection with bovine papillomavirus type 1 or human papillomavirus type 16 (HPV-16) E2 DNA enhanced CAT expression from constructions in which CAT is regulated by the ICP10 but not by other HSV promoters. Expression was not enhanced by cotransfection with HPV-16 E7 DNA. Sequence analysis of the ICP10 promoter identified a consensus E2-binding motif. Activation was significantly reduced by site-directed mutagenesis of the consensus motif.
Activation of the herpes simplex virus type 2 (HSV-2) large subunit of the ribonucleotide reductase (ICP10) gene by papillomavirus DNA encoding the E2 or E7 proteins was studied directly by immunofluorescence or by chloramphenicol acetyltransferase (CAT) analysis with hybrid ICP10 or IE175 and 38K promoter constructions. Cotransfection with bovine papillomavirus type 1 or human papillomavirus type 16 (HPV-16) E2 DNA enhanced CAT expression from constructions in which CAT is regulated by the ICP10 but not by other HSV promoters. Expression was not enhanced by cotransfection with HPV-16 E7 DNA. Sequence analysis of the ICP10 promoter identified a consensus E2-binding motif. Activation was significantly reduced by site-directed mutagenesis of the consensus motif.
Trans-activating functions described in human papillomaviruses include the E7 open reading frame that also has transforming properties and is similar to the adenovirus Ela gene (Phelps et al., 1988) , and the E2 protein that increases expression from early promoters (Phelps & Howley, 1987; Spalholz et al., 1988) . Specific E2-mediated activation depends on the presence of the palindromic consensus sequence ACC(N)6GGT (E2 response element; E2RE) (Hawley-Nelson et al., 1988) . However the E2 protein can also activate unrelated promoters that lack E2RE consensus motifs, a nonspecific effect which may involve sequences remotely related to the E2 cis elements, or it may result from the interaction of E2 with cellular transcription factors (Haugen et al., 1988) . The presence of a single E2RE motif apparently can enhance this non-specific effect (Sowden et al., 1989) . In this report we describe the activation of the promoter/regulatory region of the transforming (Hayashi et al., 1985) large subunit of herpes simplex virus type 2 (HSV-2) ribonucleotide reductase (ICP10) by E2 but not E7 DNA and indicate the involvement of an E2RE element.
Transient expression assays were used to examine the effect of the E2 protein on expression from the intact ICP10 gene and from chimeric ICP10 promoterchloramphenicol acetyltransferase (CAT) gene constructions. The plasmid pICP10-cat contains a 649bp (positions -544 to 105 relative to the mRNA cap site; 0000-9463 © 1990 SGM Fig. 1 a) fragment of HSV-2 (strain 333) DNA [map units (m.u.) : 0-554 to 0-558)] inserted 5' to the CAT structural gene . The bovine papillomavirus (BPV) long control region (LCR) target plasmid p407.1 contains the E2 enhancer region of the LCR 5' to the Simian virus 40 (SV40) minimal promoter and the CAT structural gene in pAso-cat (Spalholz et al., 1988) . Plasmids p38K-cat and pIE175-cat (O'Hare & Hayward, 1985) , and pE2-cat (Imperiale et al., 1985) , respectively contain promoter regions for the HSV small subunit of ribonucleotide reductase (positions -410 to 140), the HSV trans-activator protein IE 175 (positions -1900 to 23), and the adenovirus type 5 (Ad5) E2 protein, 5' to the CAT structural gene. pGH62 contains the HSV-1 gene for Vmw65 (O'Hare & Hayward, 1985) . It was used as a positive control for pICP10-cat and pIE175-cat activation (O'Hare & Hayward, 1985; Wymer et al., 1989) . Plasmids, pSV2cat, which contains the SV40 early promoter regulating CAT expression, and pCATB', which contains the CAT gene with no eukaryotic regulatory elements were used as positive and negative controls respectively . The intact ICP10 gene target (pGH17a m.u. 0-533 to 0-584; Fig. 2a ) was described previously (Hayashi et al., 1985) . pJW10 is a mutant of pGHl7a with a 3-86 kb deletion in the promoter/regulatory region such that it has only 52 bp of promoter DNA 5' to the mRNA cap site (positions -52 to 3688) (Fig. 1 a) . It was constructed by subcloning a Short communication 3.75 kb PvuI fragment of pGH17a into pUC18 after the addition of XbaI linkers.
CAT assays were performed in transfected Vero (African green monkey) cells as described . Transfection mixtures contained 1-0 I-tg of supercoiled target DNA and increasing concentrations of effector DNA consisting of plasmids pC59 encoding the BPV type 1 (BPV-1) E2 protein (Yang et al., 1985) , pSV2350-E2 encoding the human papillomavirus type 16 (HPV-16) E2 protein (P. Mounts, unpublished results), p1225 encoding the HPV-16 E7 protein (Phelps et al., 1988) , and pEla encoding the Ad5 Ela protein (Imperiale et al., 1985) . Parallel cotransfections employed pBR322 as non-specific DNA to equalize nucleic acid concentration effects. For expression from the intact ICP 10 gene, Vero cells were cotransfected with equimolar concentrations of pGH17a or pJW10 and pC59 or PSV2350-E2 and stained with monoclonal antibody (MAb) specific for ICP10 (MAb 30) or control MAb specific for ICP8 (MAb 27) in indirect immunofluorescence as described .
The effect of the trans-activating E2 protein on CAT expression from hybrid constructions is shown in Table  1 . CAT activity was induced by pC59 from p407.1-cat and plCPl0-cat. Activation levels were higher for the homologous (p407.1-cat) than the heterologous (plCP10-cat) construction. However dose-response patterns were similar, with maximal response observed for both target constructs at low input doses of activating DNA (0-01 to 0.03txg). plCP10-cat activation was similar in HEp-2 cells (8-1-fold activation at 0-03 ~g pC59). CAT expression from the other HSV target plasmids (piE 175-cat and p38K-cat) was not enhanced, and the parent constructs, pAso-cat and pCATB', did not respond at the doses studied in this series. Consistent with previous findings (O 'Hare & Hayward, 1985; Wymer et al., 1989) CAT expression from plE175-cat and plCP10-cat was also enhanced by DNA encoding the HSV protein Vmw65. However the Vmw65-encoding DNA did not enhance CAT expression from p407.1-cat or pA10-cat (Table 1) .
The effect of the HPV-16 trans-activating E2 protein 2.4±0-6 3.6 ± 0-5 5-3_+0-1 7-5__+0.1 p38K-cat 1.0 ± 0 1.0 ± 0 1.1 ± 0.1 1.0 ___ 0.01 pAl0-cat 1.0 + 0 1.0 + 0 1.0 ± 0 1-0 ___ 0 * Yero cells were cotransfected with various concentrations of pSV2350-E2 (HPV-16 E2 DNA) and 1.0 ktg target DNA. Results are expressed as fold increase in CAT activity over basal activity (fold activation) ±S.E.M. for plCP10-cat, p38K-cat and pAl0-cat. The results for p407.1-cat are the average of two experiments that differ by not more than 13 %. on plCP10-cat is shown in Table 2 . Unlike transact±vat±on by pC59 that was maximal at low input dose of activating DNA (0-01 to 1 gg; Table 1 ) and decreased at higher doses (3.0gg; 1.7-fold activation), pSV250-E2-induced CAT expression increased with increasing doses of activating DNA peaking beyond the concentration range shown in Table 2 . At the doses studied in these series pSV2350-E2 did not enhance CAT activity from another HSV target plasmid (p38K-cat) nor from the parent construct PAl0-cat (Table 2) .
CAT expression was not enhanced in Vero cells cotransfected with pICP10-cat and p1225 or pEla, the plasmids that express respectively the HPV-16 E7 and the Ad5 Ela proteins. This is not due to the failure of the effector plasmids to trans-activate, or to the use of inappropriate cells for cotransfection, since in the same cells both p1225 and pEla activated CAT expression from the Ad5 E2 promoter construction pE2-cat (Table  3) .
The E2-mediated enhancement is not a function of the reporter gene. Expression, defined as the number of cells staining with MAb 30, was also enhanced (five-to 10-fold) in Vero cells cotransfected with the intact ICP 10 gene (pGH17a) and the BPV-1 E2-expressing plasmid pC59 or the HPV-16 E2-expressing plasmid pSV2350-2.
Significantly, a five-to 10-fold enhancement was also observed in ceils cotransfected with pC59 and pJW10 that has only 52 bp of ICP10 promoter DNA 5' to the mRNA cap site (positions -52 to 3688, Fig. 1 a) . The staining pattern for both targets was similar to that described previously for pGH17a and there was no staining with MAb 27 specific for the unrelated HSV protein ICP8 (Fig. 2) .
Sequence analysis identified a potential E2RE within the 52 bp of ICP10 promoter DNA 5' to the mRNA cap site in pJW10 (Swain & Galloway, I986; Wymer et al., 1989) . The canonical TATA homology (GATAAAA) is located 23 bp upstream of the mRNA cap site. The consensus binding motif ACC(N)6GGT (E2RE-1) is located at positions 1 to 12, relative to the mRNA cap site. Additionally, located immediately upstream (-19 to -8) , there is an element (E2RE-2) that has a 1 bp change from the variant E2-binding motif ACCG(N)4CGGT (Fig. l b) . Oligonucleotide-directed mutagenesis was performed in order to determine the significance of the E2RE-1 motif for ICP10 regulation by the E2 protein. Briefly, the 649 bp ICP10 DNA fragment from plCP10-cat was subcloned into the SalI site of the single-stranded phage M 13mp 18 and subjected to oligonucleotide-directed mutagenesis (Muta-Gene system, Bio-Rad) with the synthetic 26 bp oligonucleotide 5' CGGTCTGGGTTAAAACAACAGGTGGG 3' complementary to E2RE-1 but containing a 2 bp transversional mutation (ACC to AAA, as underlined). After mutagenesis, progeny phage was identified by DNA sequence analysis and the fragment was recloned into pCATB' to generate the mutant construct pJW34.
Vero cells were cotransfected with pJW34 and increasing concentrations of pC59. The results summarized in Table 1 (average of three independent experiments) indicate that CAT expression from pJW34 was reduced 2-to 2.3-fold, approaching basal levels. However it was not totally abolished.
The E2 protein has been shown to trans-activate nonspecifically a wide range of viral and cellular promoters in transient expression assays. Promoters activated by the non-specific pathway are a diverse group of both cellular and viral origin (Haugen et al., 1988; Heike et al., 1989; Sowden et al., 1989) . According to Haugen et al. (1988) they include the SV40 minimal promoter, with no enhancer, that lacks E2RE motifs; their trans-activation may be due to the interaction of E2 with cellular transcription factors. Potential cis elements involved in this non-specific effect include lymphocyte-specific CLE elements (Heike et al., 1989) , G/C-rich regions (potential SP-1 sites), C T F / N F I and Octamer/NFIII binding elements (Sowden et al., 1989) . The finding that E2 stimulates expression from pICP10-cat is therefore not surprising. However, this trans-activation is not simply due to interaction of E2 with cellular transcription factors for two reasons: first, stimulation from pICP-10-cat was observed in both cell types studied in these series, and secondly, E2 protein did not stimulate CAT expression from two other HSV promoters (IE175 and 38K) in parallel experiments done in the same cells (Vero and HEp-2). Additionally we found that the SV40 minimal promoter (pA10-cat) is not activated, consistent with the findings of Spalholz et al. (1988) . Although we did not use an effector plasmid containing an E2 mutation, we believe that the effect on ICP10 is due to E2, since it was observed with plasmids encoding both BPV-1 and HPV-16 E2 protein but not with a plasmid that encodes the HPV-16 E7 protein, nor with a plasmid that encodes the Ad5 E la protein.
ICP10 activation was not reduced by deletion of promoter sequences upstream of a 52 bp segment 5' to the m R N A cap site that contains the E2-binding motif ACC(N)6GGT (position 1 to 12). However activation was reduced, albeit not abolished, by a 2 bp transversional mutation of E2RE-1, suggesting that both specific (E2RE-mediated) and non-specific component(s) are involved in activation. The contribution of the E2RE-2 element to the non-specific component of the activation is uncertain. However it may be significant that the ICP10 promoter has a consensus Octamer/NFIII element , which is absent from the IE175 and 38K promoters enhanced by neither pC59 nor pSV2350-E2.
The unexpected observation relates to the location of the E2RE-1 element. Indeed, it is well established that E2-binding sites in proximity to promoters can serve as cis response elements for activation. However, the placement of the E2RE-1 motif downstream of the T A T A box would place it in an 'operator' configuration where it might be expected to repress (Thierry & Yaniv, 1987; Lambert et al., 1987) rather than activate. Our observed activation levels are relatively modest (6.7-to 7.9-fold) but they are not inconsequential and similar findings were observed in three independent experiments. Furthermore, at the higher concentration of effector (pC59) D N A (0.1 pg) the levels of activation of pICP10-cat and p407.1-cat were virtually identical. We cannot exclude the possibility that the E2 effect is mediated through a mechanism independent of increased transcription. However activation is reproducibly decreased 2-to 2.3-fold by mutation of the E2RE-1 element, consistent with the interpretation that the E2 activation effect is real and does not represent experimental variation.
The conclusion that E2 activates ICP10 expression is of particular interest within the context of the association of both HSV-2 and HPV with cervical cancer (Aurelian et al., 1981 ; zur Hausen, 1989) . Sequences homologous to ICP10 D N A were described recently in approximately 4 0~ of cervical tumours (DiLuca et al., 1989) . However in general, detection of HSV-2 D N A in cervical tissues has been difficult (presumably reflecting low copy number) whereas gene expression, most notably of ICP10, was detected with relative ease DiLuca et al., 1989) . On the other hand both integrated and episomal HPV D N A (which contain E2 sequences) have been detected in a relatively high proportion of cervical tumours (Choo et al., 1987 (Choo et al., , 1989 Matsukura et al., 1989) . It is possible that expression of ICP10 [as well as c-myc (DiLuca et al., 1989) ] is activated by trans-activating factors such as the papillomaviral E2. In this context it may be significant to point out that the E2RE motifs are not present in the promoter (ICP6) of the large subunit of HSV-1 ribonucleotide reductase that lacks transforming potential Wymer et aL, 1989; Camacho & Spear, 1978) . The effect of E2 trans-activation on ICP10-mediated transformation is unknown. DNA sequences that encode ICP 10 transform hamster cells at a relatively high frequency (Hayashi et al., 1985) . Transforming potential was correlated with expression of the amino-terminal domain that has a serine/threonine-specific protein kinase activity ; J. P. Wymer & L. Aurelian, unpublished results) and did not require additional factors. However in view of the suggestion that patients exposed to multiple risk factors (most notably ICP10 and HPV) are at a higher risk of developing cervical cancer (DiLuca et al., 1989 ) the potential contribution of E2-mediated ICP10 activation is particularly tantalizing and merits further consideration.
